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Abstract.  Mutations in the SAC1 gene exhibit allele- 
specific genetic interactions with yeast actin structural 
gene defects and effect a bypass of the cellular require- 
ment for the yeast phosphatidylinositol/phosphatidyl- 
choline transfer protein (SEC14p),  a protein whose 
function is essential for sustained Golgi secretory 
function.  We report that SAClp is an integral mem- 
brane protein that localizes to the yeast Golgi complex 
and to the yeast ER, but does not exhibit a detectable 
association with the bulk of the yeast F-actin 
cytoskeleton. The data also indicate that the profound 
in vivo effects on Golgi secretory function and the or- 
ganization of the actin cytoskeleton observed in sad 
mutants result from loss of SAClp function.  This 
cosuppression of actin and SEC14p defects is a unique 
feature of sad alleles as mutations in other SAC genes 
that result in a  suppression of actin defects do not 
result in phenotypic suppression of SEC14p defects. 
Finally, we report that sac1  mutants also exhibit a 
specific inositol auxotrophy that is not exhibited by the 
other sac mutant strains.  This sad-associated inositol 
auxotrophy is not manifested by measurable defects in 
de novo inositol biosynthesis, nor is it the result of 
some obvious defect in the ability of sad  mutants to 
utilize inositol for phosphatidylinositol biosynthesis. 
Thus,  sac1  mutants represent a novel class of inositol 
auxotroph in that these mutants appear to require 
elevated levels of inositol for growth.  On the basis of 
the collective data,  we suggest that SAClp dysfunction 
exerts its pleiotropic effects on yeast Golgi function, 
the organization of the actin cytoskeleton, and the 
cellular requirement for inositol, through altered 
metabolism of inositol glycerophospholipids. 
T 
HE Golgi complex plays  a  fundamental  role in the 
regulation  of key aspects of intracellular  protein and 
membrane  traffic  through  the  eukaryotic  secretory 
pathway. As a result, considerable effort has been directed 
at the development of powerful biochemical and molecular 
strategies  to identify the factors that  govern  the secretory 
functions of this organelle.  In Saccharomyces  cerevisiae, the 
SEC14 gene product (SEC14p) is required for secretory pro- 
tein transport from a late Golgi compartment (Novick et al., 
1980;  Franzusoff and  Schekman,  1989).  We have  estab- 
lished that SEC14p is a peripheral membrane protein of the 
yeast Golgi whose function is essential  for cell viability and 
whose  structure  is  highly  conserved  across  significant 
phylogenetic  boundaries (Bankaitis  et al.,  1989;  Cleves et 
al.,  1991a, b; Salama et al.,  1990; H.B. Skinner  and V.A. 
Bankaitis,  manuscript in preparation).  Moreover,  we have 
demonstrated SECI4p to be the yeast phosphatidylinositol 
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(PI)l/phosphatidylcholine  (PC)  transfer  protein  (Bankaitis 
et al.,  1990). 
To date, the most penetrating  insights into the mechanism 
of SEC14p function have been obtained from a detailed anal- 
ysis of yeast mutants in which the normally essential cellular 
requirement for SECI4p is bypassed. It was demonstrated 
that mutations in any one of at least six genes could effect 
an efficient bypass of SEC14p, and it was further recognized 
that such alleles of three of these genes block PC biosynthe- 
sis via the CDP-choline pathway (Cleves et al.,  1991b). On 
the basis of those data, we proposed that SEC14p functions 
to establish a  critical  phospholipid composition in Golgi 
membranes that is required for Golgi secretory competence. 
Bypass alleles  of the  remaining  three  genes  (i.e.,  BSD1, 
BSD2,  and  SAC1)  do  not  block  PC  synthesis  via  the 
CDP-choline pathway, however, and analysis of these genes 
1.  Abbreviations  used  in  this  paper:  BCA,  bicinchoninic acid;  F-actin, 
filamentous  actin; IP,  immunoprecipitation; LSP, low  speed pellet; PC, 
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vivo.  One of these genes, SAC1, is of singular interest. Not 
only do sad alleles effect an efficient bypass of the SEC14p 
requirement, but these same alleles also suppress mutations 
in ACT/,  the actin structural gene of yeast,  in an allele- 
specific manner (Cleves et al., 1989;  Novick et al., 1989). 
These  findings have identified a  previously unanticipated 
relationship between the organization of the actin cytoskele- 
ton and the function of  a Golgi-specific phospholipid transfer 
protein in vivo, and raise the issue of what role SAClp plays 
in this relationship. 
In this report, we show that SAClp  is an integral mem- 
brane protein that localizes both to the yeast Golgi complex 
and to the yeast ER, but does not detectably associate with 
the bulk filamentous actin cytoskeleton in yeast. Moreover, 
we establish that it is loss of SAClp function that effects the 
bypass of SEC14p.  Finally, we demonstrate that sad muta- 
tions are unique among the other known sac mutations in 
their ability to suppress both sec14-associated Golgi defects 
and defects in actin cytoskeleton function, and that sacl al- 
leles are similarly unique in their phenotypic manifestation 
of a  specific  inositol  auxotrophy in  yeast.  We  offer the 
general hypothesis that the pleiotropic phenotypes associ- 
ated with SAClp dysfunction reflect alterations in some as- 
pect  of inositol glycerophospholipid metabolism in  sad 
yeast strains. 
Materials and Methods 
Strains, Media, and Reagents 
Complete genntypes of yeast strains and description of plasmids are listed 
in Table I. YP, yeast minimal and defined media have been described (Sher- 
man et al., 1983). Yeast minimal media that either lack or contain inositol 
(lmM)  and  choline  (lmM)  were  described  by  Klig et al.  (1985). Con 
A-sepharose,  TRITC-eonjugated phalloidin, poly-L-lysine, DAlai, indole- 
acrylic acid, PMSF, chymostatin, pepstatin,  leupeptin, sodium pyrophos- 
phate, myo-inositol dehydrogenase, and proteinase K were obtained from 
Sigma Immunochemieals (St. Louis, MO). The NADH monitoring kit was 
purchased from LKB-Wallac (Gaithersburg, MD), and NAD was obtained 
from  Boehringer  Mannheim  Biochemicals  (Indianapolis,  IN).  Protein 
G-Sepharose was from Pharmacia Fine Chemicals (Piscataway, NJ). Inter- 
mediate and secondary antibodies conjugated to fluorochrome were from 
Jackson ImmunoResearch (West Grove, PA). Reagents for SDS-PAGE  were 
from Bio-Rad Laboratories  (Richmond,  CA).  [35S]-labeled amino acids 
were purchased under the [35S]Trans-Label trademark  (>1,000 Ci/mmol) 
from  ICN  Radiochemicals  (Irvine,  CA).  Oxalyticase  was  from Enzo- 
genetics (Corvallis, OR). Proteinase A antiserum was obtained from E. W. 
Jones (Carnegie Mellon University, Pittsburgh, PA). The YEp(KEX2)  plas- 
mid and KEX2p antiserum were obtained from R. Fuller (Stanford Univer- 
sity Medical Center, Stanford,  CA). Yeast aetin antiserum was obtained 
from D.  Drubin  (University of California,  Berkeley, CA) and B. Haarer 
(University of Michigan, Ann Arbor,  MI). 
SAClp Antibodies 
pRE102, a plasmid consisting of  a 2.4-kb XbaI SAC1 minimal complement- 
ing fragment subcloned in the vector pTZISU (Cleves et al.,  1989), was 
Table L  Yeast Strains 
Strain  Genotype  Origin 
CTYI-IA*  MAT a,  ura3-52,  Ahis3-200,  lys2-801,  secl4-1  Bankaifis  et al.  (1989) 
CTY87  MAT a,  ura3-52,  sac1-6  P.  Noviek 
CTY88  MAT a,  ura3-52,  sac1-8  P. Novick 
CTY100  MAT a,  ura3-52,  z~is3-200,  lys2-801,  sec14-1,  sacl-26  Cleves et al.  (1989) 
CTY150*  CTY182/pCTY134  Cleves et al.  (1989) 
CTY182  MAT a,  ura3-52,  Ahis3-200,  lys2-801  Bankaitis et al.  (1989) 
CTY214  MAT a,  ura3-52,  ade2-101,  1eu2-3,112,  his4-519,  sec14-1  This study 
CTY234~  CTY182/pCTY136  This study 
CTY244  MAT a,  ura3-52,  Ahis3-200,  lys2-801,  sacl-296::HlS3  Cleves et al.  (1989) 
CTY402  MAT a,  ura3-52,  sac1-7  P. Novick 
CTY403  MAT c~, his4-619,  1ys2-803,  sacl-lO  P. Novick 
CTY404  MAT a, ade2-101,  1ys2-803,  sac1-11  P. Novick 
CTY405  MAT a,  ura3-52,  1ys2-803,  sac1-14  P. Noviek 
CTY406  MAT a,  ura3-52,  sac1-15  P.  Novick 
CTY417  MATch, ura3,  his3,  leu2,  trpl,  ino1-13  S.  Henry 
CTY443~  CTY182/pCTY101  This study 
CTY444~  CTY182/pCTY114  This study 
CTY463  MAT a,  ura3-52,  Ahis3-200,  lys2-801,  sacl-lO2::URA3  This study 
CTY558  MAT c~, ade2-101,  ade3,  1eu2-3,112,  Ahis3-200,  ura3-52,  This study 
sec  l 4A 1: :  HIS3/pCTY 11 
MAT a,  ura3-52,  Ahis3-200,  lys2-801,  secl4-1, 
sac7Al : :HIS3 
MAT a,  ura3-52,  sac2-1,  MOX1 
MAT a,  ura3-52,  sac3-1,  MOX1 
MATa, act1-3,  tub2-201,  ura3-52,  sac6-15 
CTY578  This study 
NY226  P. Novick 
NY247  P. Novick 
AAY1022  A.  Adams 
* The secl4-1 allele encodes a thermolabile SEC14p whereas all mutant sac1, sac2, and sac3 alleles listed in this table result in a cs phenotype (Bankaitis et al., 
1989; Cleves et al.,  1989; Novick et al,  1989). 
A detailed description of yeast plasmids pCTY101 and pCTY114 is given in the legend to Fig. 3 A. Plasmid pCTY136 is a YEp(URA3) vector that carries the 
yeast KEX2 gene and causes KEX2p overproduction in the host strain. Plasmid pCTY134 is a YEp(URA3) vector that carries an intact SAC1 gene and causes 
an approximate  20-fold overproduction  of  SAC 1  p in the host strain. Plasmid  pCTY  11 is a YEp(LEU2, ADE3 ) vector that carries the SEC14 gene under the control 
of an attenuated SEC14 promoter such that this multicopy  plasmid sustains the synthesis of SEC14p in yeast at a rate that is very similar to that sustained by the 
single-copy genomic SEC14 locus (not shown). 
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527-bp BclI fragment from the SAC1 clone. The deletion of the BclI frag- 
ment caused a frame shift within the SAC1 coding sequence such that the 
unique BclI site was followed by five new codons (the first two of which 
fortuitously encoded the same amino acids in those positions as the authen- 
tic SAC1 sequence) and a stop codon. The ABclI plasmid (pRE138) encodes 
the first 356 residues of the SACIp plus three new residues. Using the XhoI 
site within the SAC1 gene and the Sinai site in the vector polylinker, a 1.5-kb 
XhoLSmaI fragment that encodes SACIp amino acids 102-356  (plus three 
new residues) was removed from pREI38 and subcloned into the SalI and 
HindIII (blunt-ended) polylinker sites of pATH10  (from A. Tzagaloff),  an 
inducible expression vector that contains the promoter, operator, and cod- 
ing sequence for the trpE gene. The resultant plasmid, pREI39, encodes 
a 593 residue fusion protein representing amino acids 102-356 of  the SAClp 
(68 kD). E. coli strain RRI (Bolivar et al., 1977) bearing pRE139 produced 
some 10 mg of fusion protein per liter of  cells after an 8-h expression period 
in  tryptopban-free medium  supplemented  with  indoleacrylic  acid  (20 
/zg/ml). The hybrid protein was purified via a general procedure for TrpE 
fusion proteins (Kleid et al., 1981) and found to reside in the supernatant 
of a 0.1% SDS, 50 mM Tris, pH 7.5, 50 mM EDTA wash oftbe insoluble 
fraction of the total  cellular lysate,  mAbs were generated by  standard 
methods (Kennett, 1980).  Balb/C mice were given a primary and two boost 
injections of 50/~g of fusion protein per injection. Hybridoma cell lines 
were produced and maintained in the Hybridoma Facility, University of Il- 
linois Biotechnology Center (Urbana, IL). Culture supernatants from the 
hybridomas were screened for anti-SAClp antibodies by immunoprecipi- 
tation assays of radiolabeled yeast lysates. Two positive clones, hybridoma 
cell  lines  C5  and  C6,  were  amplified  in  cell  culture  and  the  anti- 
SAClp mAbs were precipitated from culture supernatants by addition of 
(NI-L,)2SO4 to  50%  saturation.  For  immunoprecipitation (IP)  and  im- 
munolocalization of SAClp, a mixture of these two mAbs was used. 
Identification of SAClp 
Radiolabeling of yeast with 35S-Trans label and preparation of clarified ex- 
tracts was performed as described by Bankaitis et al. (1989).  Immune com- 
plexes were recovered with protein G-Sepharose and sequentially washed 
twice with IP buffer (50 mM Tris-Cl, pH 7.5,  150 mM NaCI,  0.1  mM 
EDTA, 0.5% Tween 20), twice with urea wash buffer (2 M urea, 100 mM 
Tris-Cl, pH 7.5, 200 mM NaCI, 0.5 % Tween 20), and twice with 0.1% SDS. 
Resolution of the immunoprecipitates and autoradiography was performed 
as described by Schauer et al.  (1985).  For immunoprecipitations, SAClp 
and PrA antibodies were used at  final concentrations of 3.3  pg/ml and 
8/zg/ml, respectively. 
Fractionation of  SAClp 
Whole cell (WC), low speed pellet (LSP), 12,000 g pellet (P12), 100,000  g 
pellet (PI00), and 100,000  g supernatant (S100)  fractions derived from ra- 
diolabeled CTY182 were prepared exactly as described by Bankaitis et al. 
(1989).  Clarified extracts derived from each fraction were treated with PrA 
and SAClp antibodies. 
Na2C  0 3 Extraction 
Strain CTY150  (ODtoo  --  1.0) was radiolabeled for 1 h (100  pCi Trans- 
label/ml). After termination of radiolabel incorporation by the addition of 
NaN3 to 10 mM, the cells were washed twice in 10 mM NaN3  and then 
converted to spheroplasts by a 20 rain incubation at room temp in 1.4 M 
sorbitol, 50 mM KPi, pH 7.5,  10 mM NAN3, 20 ~g/rnl oxalyticasc. The 
spheroplasts were pelleted gently in a clinical centrifuge and subjected to 
osmotic lysis by resusponsion in 1.0 ml 0.3 M sorbitol, 10 mM MOPS, pH 
7.0. Uulysed cells and large debris were removed by centrifugation at 500 g 
for 2 min. Subsequently, 0.5 ml of clarified lysate was removed and saved 
as the WC fraction. The remaining 0.5 ml was adjusted to 0.1 M Na2CO3, 
pH  11.5, and  incubated on ice for  1 h.  The  sample was then spun at 
100,000  g for 1 h yielding the high speed supornatant (S100) and high speed 
pellet (Pl00) fractions. The PI00 was sohibilized in 1% SDS buffer (50 mM 
Tris, pH 7.5,  1 mM EDTA,  1% SDS). TCA (5% final concentration) was 
used to precipitate proteins from the WC and SI00 fractions, and these 
precipitates were solubllized in 1% SDS buffer. The WC, S100, and PI00 
fractions were then diluted in IP buffer and treated with SEC14p antiserum 
(8/tg/ml final concentration) and SAClp antibodies. 
Immunoprecipitation of  SAClp from sacl c" Mutants 
Cultures of wild type and sad  cs strains (OD60o =  1.0) were radiolabeled 
for either  1 h  or 5  min with [35S]Trans-label  (100/zCi/ml).  The corre- 
sponding extracts were subjected to immunoprecipitation with SEC14p and 
SACIp antisera by the regimen described above. 
Immunofluorescence 
Yeast strains were grown to an early logarithmic stage of  growth in complete 
minimal  medium or uracil-deficient medium  for plasmid maintenance. 
Yeast were prepared for immunofluorescence essentially as described by 
Pringle et al. (1989).  Cultures were fixed with 4% formaldehyde (final con- 
centration) first for 15 min in the culture medium and then for 12 h at 4°C 
in 100 mM potassium phosphate, pH 6.5, 0.5 mM MgC12 (buffer A). The 
fixed cells were spheroplasted for 30 min at 37°C in buffer A containing 
20  #g/ml  oxalyticase  followed  by  four  washes  in  Ix  PBS.  Washed 
spheroplasts were placed on poly-L-lysine-coated glass slides and subse- 
quently  immersed in  methanol  (-20°C)  for 6  min,  and  then acetone 
(-20°C) for 1 min. All incubations and washes were performed at room 
temp in lx  PBS,  1% BSA. After the final washes, one drop of 1 mg/ml 
p-phenylenediamine (in 90% glycerol, 0.1x PBS) was added to the stained 
cells which were then sealed under glass coverslips. The samples were pho- 
tographed using TMAX 400 film (Eastman Kodak Co., Rochester, NY) and 
a Zeiss axioplan microscope (Carl Zeiss, Inc., Thornw~xl, NY) equipped 
for fluorescence with UV filters and an HBO 50-W mercury lamp. Antibody 
incubations for localization of the SACIp were: (a) anti-SAClp antibodies 
(16 ttg/ml final concentration), 2 h; (b) 15/~g/ml rabbit anti-mouse IgG or 
sheep  anti-mouse  IgG,  1  h;  and  (c)  15  /Lg/ml FITC-conjugated  goat 
anti-rabbit IgG or TRSC-conjugated donkey anti-sheep IgG, I h. Antibody 
incubations for localization of the KEX2p were: (a) afffinity-purified poly- 
clonal rabbit anti-KEX2p serum (preadsorbed against permeabilized Akex2 
spheroplasts, 30/zg/ml final antibody concentration), 2 h; and (b) 15/zg/ml 
FITC-conjugated goat anti-rabbit IgG, 1 h. For the co-localization of actin 
and the SAClp, fixed spheroplasts were permeabilized by a 20-min incuba- 
tion in  1%  Triton X-100,  lx  PBS, washed four times in PBS, and then 
placed on polylysine-coated glass slides and allowed to air dry. Actin was 
visualized using TRITC-conjngated phalloidin (6.6 pM final concentration). 
SubceUular Fractionation 
Preparation of highly enriched Golgi fractions was performed as described 
by Cleves et al. (1991b) with minor modifications. The sorbitol gradients 
described in this work were 40-65% for the first gradient and 50-60% for 
the second gradient. Resolution of the 12,000 g pellet fractions, generated 
by the method of Cleves et al. (1991b), was performed by equilibrium flota- 
tion in a self-forming 30-55% sucrose gradient essentially as described by 
Bowser and Novick (1991). 0.5-mi fractions were collected from the top of 
the gradient and assayed for the appropriate markers. 
Construction of  a sac7Al:  :  URA3 Null Allele 
We generated a sac7AI::URA3 allele that is directly analogous to the sacZ': 
LEU2 null allele previously reported by Dunn and Shortle (1990) to repre- 
sent  an  allele-specific suppressor  of actl  ~.  Oligonucleotides  SAC7-SA 
(5'CCC_,AATICGGTACCAAATICAACGATTGG-39  and SACT-3B (5'CCG- 
CATC~CCCGGTTrATGTAACCAC~-3') were used as forward and re- 
verse primers, respectively, to generate an '~l-kb PCR product from a tem- 
plate of yeast genomic DNA. The extreme 5' end of this PCR product spans 
the Kpnl site that is situated immediately upstream of the SAC7 gene, and 
the 3' end of this product corresponds to the COOH-terminal coding region 
of SAC7 (see Dunn and Shortle, 1990).  This PCR product was subcloned 
into a AHindIII derivative ofpTZ18R as an EcoRI-SphI restriction fragment 
to yield pRE176.  This resultant plasmid was then digested with Hincll to 
release a 480-bp fragment, resulting in a deletion in the plasmid of essen- 
tially all of the coding sequence for the minimal SAC7p functional domain 
(Dunn and Shortle, 1990),  the resultant blunt ends were ligated to HindIII 
linkers,  and the yeast  URA3 gene was inserted into that newly created 
HindIII site to generate the sac7AI::URA3 plasmid pRE180. The disruption 
allele was excised as a  1.5-kb  KpnI-SphI fragment and used to transform 
strain CTYI-IA to Ura  +. The authenticity of the sac7AI::URA3 transform- 
ants was confirmed by diagnostic PCR. 
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The appropriate yeast strains were grown to mid-logarithmic  phase (OD600 
=  1.0-1.2) at 300C with shaking in the defined minimal media of Klig et 
al. (1985) supplemented with inositol and choline to a final concentration 
of 1 mM each (FC  + medium). Cells were harvested by centrifugation, 
washed four times with the same medium lacking inositol and choline 
(I-C- medium), and resuspended in 3 ml of I-C- medium for continued 
incubation at 30"C with shaking. Samples (1.5 ml) were either removed  im- 
mediately after resuspension in I-C- medium, or 3 h after resuspension, 
to yield the 0 and 180 rain time point samples, respectively.  For each sam- 
ple, cells were pelleted in an Eppendorf tube, resuspeuded  in 50/~1  of  bnifer 
I (50 mM Tris-HCL, pH 7.4, 20% glycerol, 1 mM EDTA), glass beads 
(0.2-0.3 mM diana) were added to '~75% of volume, and the tubes were 
chilled on ice. Each tube was then vortexed ten times in 30-s bursts with 
a 1-min  rest with cooling between bursts. The lysates were clarified by cen- 
trifugation for 15 rain at 14,000 g and supernatants  collected for protein and 
inositol assay. 
Inositol was quantitated by a modification of an enzyme-coupled bio- 
luminescence assay developed  by Gudermann and Cooper (1986). Briefly, 
the 80 ~1 inositol assay cocktail included 50 t~l distilled H20, 13/~1 sodium 
pyrophosphate  (0.1 M, pH 9.0), 8/~1NAD (5 raM), 1.4/~1 myo-inositol  de- 
hydrogenase  (1.5 mU/t~l), and 8 t~l of  either an appropriate dilution of  lysate 
in distilled I-I20  (to yield an input of 0.1 t~g of protein into the reaction) or 
a known inositol standard. The reaction was incubated at 25"C for 5 min 
after which time 80 ~1 of NADH monitoring reagent, prepared according 
to the method of Gudermann and Cooper (1986), was added to each assay. 
Luminescence was monitored immediately,  and recorded as a time course 
over a 5-rain period at 20-s intervals using a Lumiphot luminometer.  Inosi- 
tol content of each sample was calculated by determining the initial rates 
of increase in luminescence  vs time, and comparing these rates to those es- 
tablished for samples of  known inositol content as described by Gutermann 
and Cooper (1986). Protein concentrations were determined by the bicin- 
choninic acid (BCA) assay marketed by Pierce Bioehemicals. 
Phospholipid Analyses 
The  appropriate yeast strains were grown to an  ODt00 of ,,00.8, total 
glycerophospholipid  was extracted and resolved by ~>-dimensional paper 
chromatography exactly as described by Atkin~n (1984). Resolved phos- 
pholipid species were stained with Rhodamine  6G and visualized  under UV 
light (Christie, 1987). Individual  phospholipid  species were excised  and the 
lipids extracted from the paper with chloroform/methanol  (2:1) for 15 rain 
and dried in vacuo. Quantitation  of  phosphate  was performed by the method 
of Ames (1966). 
Results 
Identification of the SAClp 
Nucleotide  sequence  analysis of SAC1 identified an  open 
reading  frame with the potential to encode a  623  residue 
polypeptide with a predicted molecular mass of some 71 kD 
(Cleves et al.,  1989).  We used this nucleotide sequence in- 
formation to engineer the high level production of a  TrpE- 
SAClp fusion protein in E.  coli  which  was  then  partially 
purified and used as immunogen for the generation of mouse 
mAbs (see Materials and Methods). To identify SAClp, the 
appropriate  yeast  strains  were  radiolabeled  with  [35S]- 
labeled amino  acids  for  30  min  at 25"C,  and  SAClp im- 
munoreactive  species  were  precipitated  from  the  corre- 
sponding  clarified  extracts  with  a  mixture  of  these  two 
monoclonal antisera (see Materials and Methods). Vacuolar 
proteinase A (PrA) antigen, a control glycoprotein, was also 
monitored in these experiments so as to normalize the SAClp 
data. The immunoprecipitates were resolved by SDS-PAGE 
and evaluated by autoradiography. 
As the data in Fig.  1 (lane B) show, two labeled species 
were  recovered  from  wild-type yeast lysates treated  with 
both SAClp and PrA antibodies: a 65-kD species and the 43- 
kD PrA. The 65-kD species was not recovered from wild- 
type  lysates  when  preimmune  serum  was  substituted  for 
SAClp antibodies in the precipitation assay (Fig. 1, lane A), 
nor was it recovered when SAClp and PrA antibodies were 
reacted with lysate prepared from a ~sacl strain (Fig. 1, lane 
C).  Substantially increased mounts  of the 65-kD species 
(relative to PrA) were recovered from extracts prepared from 
a yeast strain carrying SAC1 on a multicopy plasmid; a strain 
expected to overproduce the SAClp (Fig. 1, lane D). By den- 
sitometry, we estimate this level of overproduction to be ap- 
proximately  20-fold  relative  to  wild-type levels.  Finally, 
pretreatment of wild-type yeast lysate with E.  coli extract 
containing the TrpE-SAClp fusion protein, against which the 
SAClp antibodies were  raised,  specifically competed pre- 
cipitation of the 65 kD species (Fig.  1,  lane F). Challenge 
of the same wild-type lysate with an equivalent amount of E. 
coli extract that was devoid of SAClp antigen exerted no such 
competitive effect (Fig. I, lane E). The combined data dem- 
onstrate that the 65-kD species represents the SAClp. Fur- 
ther confirmation of this conclusion is presented in Fig. 8 A 
where we show that several sad c, alleles encode what ap- 
pear to be truncated  forms of SAClp (see below). In vivo 
radiolabeling experiments (coupled with quantitative immu- 
noprecipitation, SDS-PAGE, autoradiography, quantitation 
by laser densitometry, and consideration of the rather mod- 
est differences in the sulfur-containing amino acid content of 
these two proteins) suggest that the SEC14p is some 15-20- 
fold more abundant than the SAClp (See Fig. 3 B, lane 2). 
Since SEC14p represents a  moderately abundant yeast cell 
protein  (ca.  0.03%  of total  cell protein;  Bankaitis et  al., 
1989),  the data identify the SAClp as a  rather inabundant 
yeast protein. 
To determine whether the SAClp is a  glycoprotein, cell- 
free lysates prepared from the SAClp-overproducing strain 
Figure  1.  Identification  of  SACIp.  Strains  CTY182  (SAC1), 
CTY244 (~sacl), and CTY150 (YEp SAC1  ) were grown in mini- 
mal medium and allowed to incorporate rsS] Trans-label for 30 
min  at 30°C.  Clarified extracts were prepared and analyzed by 
quantitative immunoprecipitation with anti-proteinase A (PrA) se- 
rum and, with the exception of lane A where preimmune SAClp se- 
rum was used, monoclonai SAClp antibodies. Immunoprecipitates 
were  resolved  by  SDS-PAGE  and  autoradiography.  Lane  A, 
CTYI82 and preimmune SAClp serum; lane B, CTY182;  lane C, 
the Asac/strain CTY244; lane D, the SAClp overproducing strain 
CTY150;  lane E, CTY182  with the addition of E. coil  extract de- 
rived from ceils not induced for synthesis of TrpE-SAClp antigen; 
lane F,, CTY182  with the addition of TrpE-SAClp antigen against 
which the SAClp antibodies were raised; lane G, the Con A-bound 
fraction prepared from clarified lysates derived from the SAClp- 
overproducing strain CTY150;  lane H, the Con A supernatant frac- 
tion prepared from CTY150 lysate. SAClp and mature PrA (mPrA) 
are indicated at left. 
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A-precipitable  and  supernatant  fractions were  generated, 
SAClp and PrA were precipitated from each fraction, and the 
corresponding immunoprecipitates were evaluated by SDS- 
PAGE and autoradiography. As shown in Fig.  1 (lane G), 
PrA exhibited the expected behavior for a glycoprotein and 
was recovered only from the Con A-bound fraction. By con- 
trast, SAClp failed to bind the Con A beads and was recov- 
ered only from the supernatant fraction (Fig.  1,  lane H). 
Taken together, these data demonstrate that SAClp is an un- 
glycosylated polypeptide, with an apparent molecular mass 
of some 65 kD, that is expressed at rather low levels in wild- 
type yeast cells. 
The SAClp Is An Integral Membrane Protein 
Inspection of the inferred SAClp primary sequence reveals 
a run of 23 uncharged amino acids, extending from residue 
522 to residue 544, that constitutes a potential membrane- 
spanning  domain  (Cleves  et  al.,  1989).  To  determine  if 
SAClp is membrane associated, we used a differential cen- 
trifugation regimen to resolve radiolabeled cell-free lysates 
into various membrane-enclosed and cytoplasmic fractions 
(see  Materials  and  Methods).  These  fractions were then 
probed for SAClp immunoreactive materials by quantitative 
immunoprecipitation with SAClp mAb. PrA was also immu- 
noprecipitated from these fractions. The conditions of  radio- 
labeling were such that a significant percentage of the total 
radiolabeled PrA was recovered in the pl and p2 forms of  the 
enzyme. These forms of the PrA zymogen served as soluble 
lumenal markers for the ER and early Golgi, and late Golgi 
compartments, respectively (Klionsky et al.,  1988). 
As shown in Fig. 2 A, the pl  and p2 forms of PrA were 
nearly quantitatively recovered from the 12,000 g (P12) and 
100,000 g (P100) pellet fractions, and no detectable amounts 
ofpl or p2 PrA were recovered from the 100,000 g superna- 
tant (S100; i.e., cytoplasmic) fraction. These data indicate 
that the cell lysis procedure preserved the integrity of the 
yeast ER and Golgi. SAClp exhibited a fractionation profile 
that was very similar to that observed for pl and p2 PrA. That 
is,  SAClp quantitatively sedimented with membranes, and 
was roughly equally distributed between the P12 and P100 
fractions (Fig. 2 A). These data, coupled with our findings 
that SAClp floats in equilibrium flotation gradients (see be- 
low), demonstrate an association of SAClp with yeast mem- 
branes and rule out the possibility that the SAClp simply 
pellets as a large protein aggregate. 
To  investigate  the  membrane  association  properties  of 
SAClp,  we determined whether alkaline pH treatment re- 
leases SAClp from membranes (Fugiki et al., 1982). In these 
experiments we used strain CTY150, the SAClp overproduc- 
ing  strain,  to  facilitate  detection of the  SAClp.  SEC14p 
served as a peripheral membrane protein/cytosolic protein 
control (Bankaitis et al.,  1989). As expected, SEC14p was 
efficiently extracted by the alkaline treatment and was recov- 
ered only from the S100 fraction (Fig. 2 B). By contrast, 
SAClp was  recovered exclusively from the P100 fraction. 
Identical  SAClp  extraction  profiles  were  obtained  when 
these  experiments  were  performed  with  wild-type  yeast 
strains (data not shown), thereby indicating that the mem- 
brane-association properties of SAClp are not altered when 
the polypeptide is overproduced. In other experiments, we 
found that the majority (ca. 80%) of the SAClp partitioned 
Figure 2. Membrane association properties of SACIp. (A) Differen- 
tial centrifugation. Strain CTY182 (SAC1) was radiolabeled and the 
resulting osmotic lysate was subjected to three rounds ofcentrifuga- 
tion (see Materials and Methods). The whole cell (WC), 12,000 g 
pellet (P12), 100,000 g supernatant (SIO0), and 100,000 g pellet 
(PIO0) fractions were probed for the presence of precursor forms 
of PrA and SAClp. The pl and p2 PrA, indicated at left, serve as 
lumenal markers for ER and early Golgi, and late Golgi, compart- 
ments, respectively. Note that the WC fraction was derived from 
one-half of  the material that was used to generate the other fractions 
(see Materials and Methods). Our recoveries of antigen after frac- 
tionation typically exceeded 85 %. (B) Alkaline nonextractability 
of SAClp. The SACIp overproducing strain CTY150 was radiola- 
beled and an osmotic lysate was prepared. One-half of  that cell-free 
lysate was saved as the whole cell (WC) fraction and the remainder 
was adjusted to 0.1 M Na2CO3 (pH 11.5). After a 1-h incubation 
on ice, the Na2CO3 fraction was centrifuged at 100,000 g and the 
resulting S100 and P100 fractions were probed for the presence of 
SAClp and SEC14p, a peripheral membrane protein control. 
into the detergent phase upon solubilization of osmotic ly- 
sates with Triton X-114 and subsequent resolution of aque- 
ous and detergent phases (data not shown). These data indi- 
cate that SAClp is an integral membrane protein. 
Localization of the SAClp by Immunofluorescence 
To detect SAClp by immunofluorescence methods, we used 
an antibody sandwich method that had previously been suc- 
cessfully applied to the localization of  other inabundant yeast 
proteins (Pringle et al.,  1989). Visualization of the SAClp 
staining profile of wild-type yeast cells revealed a faint, but 
reproducible, punctate pattern (Fig. 3 A, lane 2). Further ex- 
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and 5. We generally observed between three and eight FITC- 
stained bodies per cell in any given focal plane, and >90 % 
of the yeast cells exhibited this pattern. This punctate stain- 
ing was not associated with either the nucleus or the mito- 
chondria,  as judged by the lack of colocalization of FITC- 
stained structures with DAPI-stained structures  (Fig.  3 A, 
lane 2). We address the identity of these punctate structures 
below. Moreover, we occasionally found cells that, in addi- 
tion to the punctate staining,  also exhibited what appeared 
to be a fainter nuclear envelope staining for SAClp. An ex- 
ample of such SAClp staining is presented in Fig. 4  (panel 
2).  Those  punctate  and  nuclear  envelope  SACIp  staining 
profiles are considered to reflect the authentic distribution of 
the SAClp as sac1  ° yeast strains failed to exhibit any detect- 
able  FITC-staining  under  these  experimental  conditions 
(Fig. 3 A, lane 1 ). Furthermore, preincubation of 3AClp an- 
tibodies with TrpE-SAClp fusion protein, but not TrpE anti- 
Figure 3. Localization of  SAClp. (A) Immunofluorescence localization of  SAClp. Fixed yeast cells were permeabilized and stained for SAClp 
using an antibody sandwich consisting of primary anti-SAClp mouse mAbs, secondary rabbit anti-mouse IgG serum, and tertiary  goat 
anti-rabbit IgG conjugated to fluorescein isothiocyanate (FITC). Nuclei and mitocbondria were stained with the DNA stain DAPI. Isogenic 
yeast strains engineered to produce varying relative amounts of SACIp  were employed in these experiments. Lane 1, strain CTY463 (Asad); 
lane 2, strain CTY182 (SAC/);  lane 3, strain CTY444 (YEp SAC1);  lane 4, strain CTY443  (YCp SAC1).  The YEp(SAC1) plasmid in 
strain CTY444 (i.e., pCTY114) harbors  a 2.4-kb XbaI fragment that bears a promoterless,  albeit otherwise  intact,  SAC1 gene (Cleves 
et al., 1989). The YCp(SAC1 ) plasmid carded by strain CTY443 (i.e., pCTY101) harbors a 7.5-kb Sstl-Sphl genomic DNA fragment that 
includes the entire SAC1 gene and the complete SAC1 promoter. Both pCTY101 and pCTYll4 carry URA3 as a selectable marker.  (B) 
Quantitation of relative SACIp amounts. The corresponding  yeast strains used in the immunofluorescence experiments described  in the 
legend to Fig. 3 A were radiolabeled for 30 rain at 30°C, clarified extracts were prepared from the corresponding  ~  precipitates,  and 
SAClp and SEC14p immunoreactive materials were recovered by quantitative immunoprecipitation and resolved by SDS-PAGE and autora- 
diography. The SEC14p signal served to normalize the SAClp data.  The lane designations correspond  exactly to those in Fig. 3 A. 
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yeast cells that were subjected to this immunofluorescence 
regimen (data not shown). 
The nuclear envelope component of SAClp immunostain- 
ing became more pronounced when the amount of SAClp 
produced by yeast cells  exceeded  wild-type levels.  Yeast 
strains CTY444 and CTY443 were engineered to exhibit a 
modest overproduction of the  SAClp  (see  Materials  and 
Methods).  Quantitative  immunoprecipitation analysis  re- 
vealed that these strains overproduce SAClp some three- and 
sixfold relative to wild-type, respectively (Fig. 3 B, lanes 3 
and 4). Strain CTY444 exhibited a predominantly punctate 
SAClp-staining pattern that was very similar to that observed 
for wild-type cells, only more intense (Fig.  3 A, compare 
lanes 2 and 3). By contrast, when CTY443 was analyzed by 
immunofluorescence, both punctate and nuclear envelope 
SAClp-staining profiles were observed in essentially all of 
the ceils (Fig. 3 A, lane 4).  Comparison of the FITC- and 
DAPI-staining patterns recorded for strain CTY443 demon- 
strate coincidence of the nuclear envelope with SAClp stain- 
ing. Furthermore, treatment of either wild-type or SAClp- 
overproducing yeast strains with cycloheximide  for 1 h before 
fixation did not alter the corresponding SAClp localization 
profiles of these strains (not shown). Thus, no net chase of 
nuclear envelope SAClp staining into punctate staining was 
observed, nor vice versa. We currently interpret these data 
to suggest two compartments of steady-state residence for 
the SAClp in the yeast cell, and consider the nuclear enve- 
lope-associated SAClp staining to likely reflect some local- 
ization of this polypeptide to the yeast ER system. This con- 
clusion is based on the similarity of this pattern of SAClp 
staining to the profile previously described for the lumenal 
ER marker KAR2p (Rose et al.,  1989),  and is further sup- 
ported by subcellular fractionation experiments (see below). 
We also note that, under conditions of modest SAClp over- 
production, apparent SAClp staining of the plasma mem- 
brane could occasionally be observed (see Fig. 3 A, panel 
4). On the basis of experimental evidence presented below, 
Figure 4. Double-label  immunofluorescence  staining of  the filamentou  s actin cytoskeleton  and SAClp in yeast. Strain CTY443 was prepared 
for immunofluorescence as described in Materials and Methods. The F-actin cytoskeleton was stained with phalloidin conjugated to 
tetramethylrhodamine isothiocyanate (TRITC). The SAClp was visualized using an antibody sandwich consisting of anti-SAClp mAbs, 
rabbit anti-mouse IgG, and goat anti-rabbit IgG conjugated to fluorescein isothiocyanate  (FITC). Nuclei and mitochondria were stained 
with DAPI. 
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described in Materials and Methods. KEX2p was stained with primary rabbit polyclonal anti-KEX2p serum and secondary FITC- 
conjugated  goat anti-rabbit IgG serum. SAClp  was stained using an antibody sandwich  consisting  of  anti-SAClp  mouse monoclonal  primary 
antibodies, sheep anti-mouse IgG secondary antibodies, and Texas  red sulfonyl  chloride (TRSC)-conjugated  donkey  anti-sheep Ig(3  tertiary 
antibodies. 
we believe this component of SAClp  staining to reflect the 
presence of SAClp in the peripheral ER that lies immediately 
underneath the plasma membrane (Kaiser and Schekman, 
1990). 
SAClp Does Not Detectably Associate with the Bulk 
of the Yeast F-Actin Cytoskeleton 
To  determine whether the  punctate aspect of SAClp  im- 
munofluorescence staining represents localization of SAClp 
to plasma membrane-associated patches of filamentous- (F-) 
actin, termed cortical actin patches (Kilmartin and Adams, 
1984),  we performed a series of double-label immunofluo- 
rescence experiments. 
Yeast  cells  were  fixed,  permeabilized,  and  stained  for 
SAClp by the antibody sandwich technique described above 
using an FITC-conjugated tertiary antibody. The cells were 
then co-stained with TRITC-conjugated phalloidin, a probe 
for F-actin. Visualization of the rhodamine staining profile 
of these wild-type yeast cells revealed the actin cables and 
cortical actin patches of the F-actin cytoskeleton in yeast 
(Fig.  4;  Kilmartin and Adams,  1984).  The cortical actin 
patches are represented by the punctate F-actin staining that 
is prominently displayed in panels 1-3 of Fig. 4. These corti- 
cal patches were not coincident with either the SAClp punc- 
tate staining profile, as determined by FITC fluorescence, or 
nuclear and mitochondrial staining, as determined by DAPI 
fluorescence.  Furthermore, the actin cables,  most promi- 
nently featured in panel 2, were not arranged in a manner 
that suggested some extensive association with SAClp punc- 
tare or perinuclear staining. These data indicate that:  (a) 
SAClp was not localized to cortical actin patches, and (b) that 
SAClp  did  not exhibit  some global  association with  the 
F-actin cytokeleton; at least not within the limits of  detection 
of this technique. However, we were able to co-recover, in 
a SAClp-dependent manner, both SAClp and actin from cell- 
free  lysates  by  native  immunoprecipitation  using  either 
affinity-purified actln-specific  antibodies  or  monoclonal 
SAClp antibodies as affinity probes (data not shown). The 
difficulties  of  absolutely  excluding  some  artifactual  co- 
recovery of SAClp  with the abundant actin polypeptide in 
such experiments, coupled with the failure of initial attempts 
to recover SAClp/actin complexes in cross-linking experi- 
ments, preclude a firm interpretation of those co-precipita- 
tion data. Nevertheless, such data leave open the possibility 
that SAClp  associates with G-actin or actin oligomers in 
vivo. 
SAClp Localizes to Yeast Goigi 
To investigate the possibility that the punctate bodies stained 
with SAClp antibodies represent yeast Golgi bodies, we as- 
sessed the co-localization of SAClp with KEX2p, an integral 
membrane protein  of the yeast Golgi  (Franzusoff et  al., 
1991; Redding et al., 1991). Strain CTY234, a KEX2p over- 
producing strain, was used for those studies. Fuller and col- 
leagues have shown that yeast bearing the KEX2 gene on a 
multicopy plasmid exhibit normal localization for KEX2p, 
and that the amplified KEX2p staining can be readily de- 
tected  without  having  to  resort  to  antibody  sandwich 
methods (Franzusoff et al.,  1991; Redding et al.,  1991). To 
visualize KEX2p,  fixed, and permeabilized cells of strain 
CTY234 were incubated with affinity-purified rabbit poly- 
clonal anti-KEX2p serum and FITC-conjugated goat anti- 
rabbit IgG. SAClp was detected using an antibody sandwich 
consisting of primary anti-SAClp mouse mAbs, sheep anti- 
mouse IgG, and developed with Texas Red sulfonyl chloride 
(TRSC)-conjugated  donkey  anti-sheep  IgG.  Appropriate 
controls were performed to insure the specificity of the an- 
tisera and to verify the spectral  separation of the fluoro- 
chromes under the photographic conditions employed (not 
shown).  Fig.  5  shows representative cells from the '~100 
cells that were examined in these studies. The upper panels 
show the punctate staining that is characteristic of KEX2p 
localization (Cleves et al.,  1991; Franzusoff et al.,  1991; 
Redding et al., 1991), and the lower panels show the corre- 
sponding SAClp localization in the same cells. Inspection of 
these cells revealed a significant, but not absolute, coinci- 
dence of SAClp and KEX2p staining bodies (Fig. 5). We es- 
timate that >50%  of the punctate SAClp-staining bodies 
scored positive for KEX2p, and vice versa. 
The biochemical cofractionation of SAClp with two Golgi 
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Figure 6. Quantitation of SAClp in highly enriched Golgi fractions.  (A) Distribution  of marker proteins in supernatant and pellet fractions. 
Wild-type (CTY182) cells were grown at 25°C in YPD medium, converted to spheroplasts,  and osmotic lysates prepared and fractionated 
essentially  as previously described (Cleves et al.,  1991). The Pl00 fraction was further resolved by equilibrium flotation  centrifugation 
in a 40-65 % sorbitol gradient and 1.0-ml fractions were collected from the top and assayed for the appropriate markers.  The KEX2p peak 
fraction pool from this first gradient was designated  the GRAD#1  fraction and was then further resolved  by equilibrium  sedimentation 
cantrifugation in a second 50-60% sorbitol gradient, 0.5-ml fractions were collected from the top, and analyzed for the indicated markers. 
The KEX2p peak fraction pool from this  second gradient was designated as the GRAD#2 fraction, The relative  quantities  of KEX2p, 
SEC14p, and SAClp in each fraction were determined by quantitative  ELISA (see Cleves et al.,  1991b) using 1.66/~g/ml,  5.7/~g/xnl, and 
2.24/~g/rnl of antibody,  respectively.  Enzyme activities  of the ER marker NADPH cytochrome c reductase (CC RED) are expressed  as 
umoles of cytochrome c reduced per min per fraction.  (B and C) Graphic representation of marker protein distribution  across the first 
40-65% and second 50-60%  sorbitol gradients,  respectively. 
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tion of a method we have previously described for obtaining 
highly enriched yeast Golgi fractions that are substantially 
free  of contamination  by the plasma  membrane  or  ER, 
vacuolar,  and  mitochondrial  membranes  (Cleves et  al., 
1991b). We also monitored the distribution of  an ER marker, 
NADPH cytochrome c reductase,  throughout the fraction- 
ation. The data presented in Fig. 6 A show that most of the 
KEX2p (68 % of total) was recovered in the P100 fraction. 
The  SAClp, SEC14p, and  cytochrome  c  reductase  dis- 
tributed more equally between the P12 and P100 membrane 
fractions. Further resolution of  the P100 fraction by equilib- 
rium flotation in a self-forming 40-65 % sorbitol  gradient 
demonstrated coincidence of the peak KEX2p, SEC14p and 
SAClp fraction pools (Fig. 6 B), containing 60, 18, and 45 % 
of total material, respectively. Moreover, satisfactory recov- 
eries of antigen were obtained as 88, 86, and 94 % of input 
material  was recovered from the peak  fraction  pools  for 
KEX2p,  SEC14p,  and  SAClp, respectively.  Most  of the 
cytochrome c reductase was recovered from denser fractions 
and some was pelleted to the bottom of the tube as well. Al- 
though the peak cytochrome c reductase fractions could be 
distinguished from the peak KEX2p,  SEC14p and SAClp 
fractions (Fig. 6 B), the fractions were pooled in such a man- 
ner that some 24 % of the total cytochrome c reductase was 
still present  in the KEX2p/SEC14p/SAClp peak fraction. 
The final step involved resolution of the pooled membranes 
by equilibrium sedimentation in a self-forming 50-60 % sor- 
bitol gradient. Again, the KEX2p, SEC14p and SAClp peak 
profiles in the sedimentation gradient were largely coinci- 
dent (Fig. 6 C) although the SEC14p and SAClp peaks each 
exhibited a trail into lighter fractions whereas the KEX2p 
peak did not. Indeed, the SEC14p and SAClp peak profiles 
were nearly superimposable. Some 57 % of  the total KEX2p 
(95 % of input) was recovered in the peak KEX2p fractions 
collected from this gradient,  and 26%  of the total SAClp 
(58% of input) was recovered in those KEX2p peak frac- 
tions. Approximately 94 % of  the input SAClp was recovered 
in the SAClp-containing fractions  of this  gradient.  Cyto- 
chrome c reductase sedimented quantitatively to the bottom 
of the gradient,  and <1% of total reductase was recovered 
in the KEX2p peak fractions. Thus, a significant percentage 
of the total SAClp coemiched with the yeast Golgi integral 
membrane protein marker KEX2p and the peripheral Golgi 
protein SEC14p. 
SAClp Also Resides in the Yeast ER 
As approximately 50% of  the total cellular SAClp was recov- 
ered in the P12 fraction, along with the majority of the ER 
and plasma membrane markers (i.e., NADPH cytochrome 
c  reductase  and plasma  membrane  ATPase, respectively; 
Fig. 6 B and Cleves et al., 1991b), we further fractionated 
the P12 to assess the distribution of the SAClp with respect 
to ER and plasma membrane markers. The P12 was gener- 
ated as described above, and determined to contain 54, 63, 
43,  and  8%  of the total cytochrome  c reductase,  plasma 
membrane ATPase, SAClp, and KEX2p, respectively (data 
not shown). The P12 was then further resolved by equilib- 
rium flotation in a self-forming 30-55 % sucrose gradient by 
the method of Bowser and Novick (1991). Representative 
data are shown in Fig. 7. In this system, we were able to par- 
tially resolve  ER from plasma  membrane fractions.  The 
cytochrome c reductase was primarily localized to two dis- 
tinct peaks. Approximately 20 % of the total cytochrome c 
reductase was recovered in the less dense peak pool (frac- 
tions 11-15), whereas 19% of the total was recovered in the 
denser peak pool (fractions 16-19). This 39 % recovery of  to- 
tal cytochrome c reductase in these two peaks represented 
a 91%  recovery of enzyme loaded into the gradient.  The 
plasma  membrane  ATPase fractionated  in  a  single  peak 
(fractions  18-22)  that contained  31%  of the total plasma 
membrane ATPase (49 % of input) and was denser than the 
ER peaks. The minor cellular fraction of KEX2p present in 
the P12 came offthe  gradient in a single peak (fractions 9-12) 
that was less dense than any of  the ER and plasma membrane 
peaks (Fig. 7).  These profiles are in good agreement with 
those reported by Bowser and Novick (1991). SAClp was re- 
covered primarily in a single peak that encompassed frac- 
tions 15-20 and contained 20% of total SAClp (48% of in- 
put). This peak coincided almost exactly with the denser of 
the two cytochrome c reductase peaks. Indeed,  some 17% 
of the total cellular SAClp (40 % of input) was recovered in 
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Figure 7. SAClp cofractionates with ER membranes. P12 fractions 
were generated as described in the legend to Fig. 6 A, and the frac- 
tion of  total  intracellular  NADPH  cytochrome c reductase,  vana- 
date  sensitive  plasma membrane ATPase, KEX2p, and  SACIp in  the 
P12 was determined  as described (Cleves et al., 1991b). The P12 
was  subsequently resolved by equilibrium flotation in a  self- 
forming 30-55 % sucrose gradient by the method of Bowser and 
Novick (1991), 0.5-ml fractions  were collected from the top of the 
gradient to the bottom, and the various markers were quantitated 
in each fraction. The relative activities, or quantities, of each 
marker are expressed on a per 1-ml fraction. 
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amount of SAClp (11% of total; 26 % of input) was recovered 
in the plasma membrane fractions as well (Fig. 7). We note, 
however, that ,'~15% of total cytochrome c reductase (34% 
of input) was also recovered from those peak plasma mem- 
brane fractions (18-22).  As a result, the contamination of 
plasma  membrane fractions by ER can  fully account for 
SAClp detected in those fractions. Since we have failed to 
gain access to SAClp by protease shaving of intact sphero- 
plasts, or by extrinsic labeling of surface exposed proteins by 
radioiodination methods (not shown), we consider the col- 
lective data  to  be  most  consistent  with  a  localization of 
SAClp to a  subfraction of ER membranes,  in  addition to 
Golgi membranes. 
Suppression of  SEC14p and Actin Defects Occurs 
Through Loss of SAClp Function 
The sad null (sad  °) phenotype is cold sensitivity for growth 
(Novick et al.,  1989; Cleves et al.,  1989). Since all of the 
available  sad  alleles  render  the  corresponding  mutant 
strains  cs  for growth,  regardless  of whether these alleles 
were  initially  identified  as  suppressors  of actl-1 ~  or  of 
sec14-1% it seems likely that suppression in both cases in- 
volves loss  of SAClp  function.  However, the finding  that 
sac1  ° mutations result in a phenotypicaily less efficient sup- 
pression  of act1-1  ~ or  sec14-1  ~ lesions  has  prompted  the 
suggestion that suppressor sad ~ alleles attenuate, but may 
not eliminate, SAClp function (Novick et al.,  1989; Cleves 
et al.,  1989). As a resolution of this issue is crucial to the 
understanding of how SAClp relates to both actin and Golgi 
function in yeast, we wished to examine this point further 
by  analyzing  the  SAClp  profile  from  21  representative 
sacl  cs  strains.  Fourteen of the corresponding alleles were 
isolated as  suppressors of seal4-1 '~ whereas the remaining 
seven were identified as suppressors of actl-1 ~.  The appro- 
priate strains were radiolabeled for 1 h  at 30°C with 3sS- 
labeled amino acids,  SAClp and  SEC14p immunoreactive 
materials were recovered, and the products were analyzed by 
SDS-PAGE,  and  autoradiography.  The  SEC14p  signal 
served to normalize the SAClp data. 
The sac1" mutations fall into three general classes with 
respect to the form of SAClp that was detected in lysates pre- 
pared from the corresponding mutants. Representative data 
for each of these classes are shown in Fig. 8 A, while a com- 
prehensive tabulation of the data is presented in Fig.  8 B. 
Class  I  is  represented by six sac1  cs alleles and the corre- 
sponding mutants exhibited a form of SAClp that, by SDS- 
PAGE, was indistinguishable from wild-type SAClp.  More- 
over, the amount of SAClp antigen recovered from the class 
I mutants was not significantly reduced relative to that recov- 
ered from the wild-type strain.  Class II mutants, however, 
produced a truncated form of SAClp, and four sad" alleles 
fall into this category. The SAClp species encoded by the 
three class II alleles represented in Fig.  8 A (i.e., sac1-6  ~, 
sad-11", sacl-14 ") exhibited molecular masses of "~53 kD, 
52 kD, and 55 kD, respectively. Finally, the remaining  11 
sad" alleles define the class IN category. The correspond- 
ing mutants failed to produce detectable SAClp antigen un- 
der the radiolabeling conditions described. Since these ex- 
periments involved a relatively long period of radiolabeling 
(1 h), we have also attempted to visualize SAClp antigen in 
class  1/I  mutants  under conditions of pulse-radiolabeling. 
Figure 8. SACIp profiles of sac1  cs yeast. (A) The appropriate yeast 
strains were radiolabeled for 1 h at 30°C and converted to clarified 
extracts after termination of labeling by addition of TCA to a final 
concentration of 5 %. These extracts were then probed for SAClp 
and SEC14p antigen by quantitative immunoprecipitation,  SDS- 
PAGE, and autoradiography. The SEC14p signal served to normal- 
ize the SAClp data.  Relevant genotypes are indicated at bottom. 
Mutant classes are as follows: class I, Saclp" migrated as a full- 
length species; class II, Sacll~' behaved as a truncated polypeptide 
on SDS-PAGE; class IN, no detectable SAClp antigen was recov- 
ered. (B) Tabulation of sad  cs mutant classes. The 21 sad  cs alleles 
analyzed for SAClp profile are categorized by the classification de- 
scribed in the legend to Fig. 8 A. 
We have used pulse radiolabels of as short as 5 min and still 
have failed to detect SAClp antigen in those mutant lysates. 
This  inability  to  detect SAClp  antigen  in  class  HI sad" 
strains is considered significant as the wild-type SAClp ex- 
hibits a half-life of ,',,1 h at 30°C (not shown). The simplest 
interpretation of these collective data is that the class HI 
sac1 ~ alleles are essentially equivalent to sad* alleles, and 
these data are most consistent with a  model in which the 
mechanism of act1-1  ~ and sec14-1  ~ suppression involves loss 
of SAClp function. This model predicts that sac1 disruption 
mutations should result in a bypass of the normally essential 
SEC14p  requirement and,  consequently, a  suppression of 
secl4 disruption alleles. This prediction was fulfilled by our 
ability to directly transplace the haploid-lethal seal4-129:: 
HIS3 disruption (described in Bankaitis et al.,  1989) into 
sad  ° haploid strains by transformation. 
Suppression of  SEC14p Defects is not a General 
Property of  Mutations in SAC Genes 
Previous work has identified other SAC genes, clearly dis- 
tinct from SAC1, whose products represent candidate actin 
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1990; Adams et al.  1989). As in the case of SAC1, the SAC2 
and SAC3 genes were identified on the basis of the isolation 
of cs mutations that exhibit a recessive and allele-specific 
suppression of act1 ~ mutations (Novick et al.,  1989). SAC7 
was similarly identified in an actin suppressor screen and, 
while suppressor sac7 alleles exhibit both co-dominant and 
recessive phenotypic traits, both the allele-specificity of the 
suppression of actin mutations and the synthetic lethality as- 
sociated with  specific combinations of sac7 and act1  ~ al- 
leles closely resembles the genetic interactions observed be- 
tween sac1  and  act1  ~ alleles  (Dunn  and  Shortle,  1990). 
SAC6 was identified in a screen for dominant suppressors of 
act1 ~ (Adams  et  al.  1989).  Penetrating  insights  into  the 
mechanism of function have been obtained for only one of 
these  gene  products.  Adams  et al.  (1989)  have provided 
strong evidence to indicate that the SAC6p is the yeast ver- 
sion of the actin bundling protein fimbrin. To determine if 
phenotypic suppression ofsecl4 mutations is a general prop- 
erty of sac mutations, we combined the appropriate sac al- 
leles with defined sec14  alleles in haploid yeast and then 
scored phenotypic suppression of secl4 defects. 
The data show sacl alleles to be unique in their ability to 
suppress sec14 defects.  Introduction of the dominant sup- 
pressor of actin allele sac6-2 had no effect on the cellular re- 
quirement for SEC14p function as evidenced by the failure 
of this dominant sac6-2 allele to effect any detectable pheno- 
typic suppression of sec14-1  ~ or sec14Zkl::HIS3.  Suppres- 
sion  of the normally lethal sec14~l::HIS3  lesion was  as- 
sessed by a plasmid shuffle/colony sectoring assay that tested 
whether a yeast centromeric plasmid bearing the sac6-2 al- 
lele (i.e., pAAB162; see Adams et al., 1989) was able to re- 
lieve the dependence of a  sed4Al::HIS3 strain (CTY558; 
Table I) on the presence of a SEC14 plasmid for viability (not 
shown).  The recessive suppressor of actin alleles sac2d" 
and sac3-1" also failed to phenotypically suppress sec14-1'*, 
as judged by the uniform 2:2 segregation of Ts+/Ts  - pheno- 
types in the meiotic progeny obtained from each of the 10 
and  12 asci analyzed from genetic crosses where sec14-1  ~ 
and  sac24",  and  sec14-1  ~ and  sac3-1"  were  segregating, 
respectively. If these sac'* alleles were to suppress sec14-1  ~, 
we would have expected the majority (ca. 75%) of asci to 
have yielded greater than two "Is  ÷ meiotic progeny apiece. 
Moreover, we readily recovered sec14-1  #, sac'* double mu- 
tant meiotic progeny from these crosses,  as  identified by 
their dual ts,cs phenotypes. Finally, a sacTAI::URA3 null al- 
lele (see Materials and Methods), an allele that is directly 
analagous to a sacZ':LEU2 disruption allele shown by Dunn 
and Shortle (1990) to suppress actin defects, also was unable 
to  effect a  phenotypic  suppression  of either  sec14-1  ~ or 
sed4z~l::HIS3. Again, suppression of the latter was assessed 
by testing whether a genomic sacTAI::URA3 allele could re- 
lieve the dependence of a sed4~l::HIS3 strain (CTY558; 
see Table I) on the presence of a SEC14 plasmid for viability. 
Suppression of sec14-P was assessed by transplacement of 
sac7~l::URA3 into a haploid sec14-1  ~ strain (CTYI-IA; Ta- 
ble I) and scoring the desired recombinants for phenotypic 
suppression of sec14-1  # (see Materials and Methods). 
Thus, sad alleles are unique with respect to their ability 
to suppress both specific actin defects and wholesale defects 
in SEC14p function. The distinction between sac1 and sac7 
mutations in this regard is especially noteworthy as sac1 and 
sac7 mutations exhibit a very similar allele specificity not 
only with respect to which actin mutations these suppress 
(i.e., actl-l#),  but also with respect to which actin muta- 
tions (i.e., act1-2  ~) result in synthetic lethality when com- 
bined with these sac mutations in a haploid yeast cell (No- 
vick et al.,  1989; Dunn and Shortle,  1990). 
sac1 Mutants are Inositol Auxotrophs 
During the course of these studies, we noted that sac1 mu- 
tants fail to grow in inositol-free media. As wild-type yeast 
strains have de novo inositol biosynthetic capability, this ino- 
sitol auxotrophy represents a new sacl-associated phenotype 
and is illustrated in Fig. 9 A. The growth characteristics of 
a  number of sac1  strains on inositol-free and inositol sup- 
plemented media were compared to those of a SAC1 strain 
and a known inositol auxotrophic strain (ino1-13). The inol- 
13 strain is deficient in inositol-l-phosphate synthase activity 
and  fails  to  convert  glucose-6-phosphate  to  inositol-1- 
phosphate, a direct intermediate in inositol biosynthesis in 
yeast (for a review see Carman and Henry, 1990). The data 
indicate that: (a) sac1 strains failed to grow (i.e., form iso- 
lated colonies) on inositol-free medium; (b) the severity of 
this growth defect closely resembled that of the ino1-13 mu- 
tant; and (c) this growth defect was inositol remedial. The 
growth capabilities of the other sac mutants were also tested 
on media either containing or lacking inositol. The data are 
presented in Fig. 9 B. Clearly, all of the other sac mutants 
exhibited rather normal growth properties irrespective of  the 
inositol content of  the media. These phenotypic data indicate 
that sac1 mutants are unique among the sac mutants not only 
in their suppression of sec14 defects, but also in their inositol 
auxotrophy. 
Measurement of  Intracellular Inositol Pools in 
sac1 Mutants 
Several indirect lines of evidence suggested that the inositol 
auxotrophy associated with sac1 mutations was not likely to 
be  the  simple  result  of an  inositol  biosynthetic  defect. 
Genetic mapping and nucleotide sequence data indicate that 
the structural genes for: (a) yeast inositol-l-phosphate syn- 
thase (IN01); (b) the transcriptional activators of IN01 (i.e., 
IN02 and IN04); and (c) SAC1, are clearly distinct (Dona- 
hue and Henry, 1981; Klig and Henry, 1984; Novick et al., 
1989; Cleves et al.,  1989; Hoshizaki et al.,  1990; Nikoloff 
et al.,  1992).  Second, the ino1-13 allele fails to suppress 
sec14-1  ~ and does not manifest itself in a cs growth pheno- 
type (not shown). Finally, the cs growth defects and suppres- 
sor phenotypes associated with sacl  mutations are mani- 
fested in media containing sufficient inositol to overcome 
any inositol biosynthetic defects. 
To more directly assess whether sad mutants suffer an in- 
tracellular inositol deficit when shifted to inositol-free me- 
dia, we measured intracelhlar inositol pools in wild-type, 
inol, and sad mutant strains as a function of inositol depri- 
vation. As shown by the data in Fig.  10 A, the intracelhlar 
inositol pools of the wild-type, ino1-13, and sacl-26 mutant 
strains immediately after shift to inositol-free medium were 
of similar magnitude, ranging from •2.5  moles inositol//~g 
protein in the case of the wild-type and ino1-13 strains down 
to 2.0 moles inositol/#g protein for the sacl-26mutant. Al- 
though these values were quite similar, we note that the inosi- 
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medium either supplemented  with inositol (+/NO), or left nnsupplemented (-/NO), and incubated  at 26°C for 96 h. The strains  are as 
follows: (a and e) CTY182 (wild-type);  (b and  f) CTY417 (ino1-13); (c) CTY100 (sacl-26); (d) CTY403 (sad-lO);  (g) CTY567 (sac24); 
(h) CTY568 (sac34); (i) AAY1022 (sac6-15); and (j) CTY578 (sacTAI::URA3). 
tol pools of the sacl-26 mutant were slightly, but reproduci- 
bly, lower than those of the wild-type and ino1-13 strains.  At 
this time we do not consider this to be a  significant differ- 
ence.  Deprivation of wild-type cells for exogenous inositol 
for a 3-h period had no significant effect on intracellular ino- 
sitol pools. In marked contrast, similar challenge of the inol- 
13 mutant resulted in almost a 6-fold reduction in its inositol 
pools relative to those measured for this strain immediately 
after  shift  into  inositol-frcc  medium (Fig. I0 A). We pre- 
sume  that  this  loss of inositol  pool homeostasis  was  a 
manifestation  of  the  inol-13-associated  inositol  biosynthetic 
defect.  As in  the  case  of  the  wild-type  strain,  a 3 h inositol 
deprivation  did not elicit  any appreciable  reduction  in the 
inositol  pools  of  the  sacl-26mutant strain  (Fig.  10  A).  From 
these data we infer that sacl mutants were not defective in 
inositol biosynthesis. 
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thesis nor in inositol utilization. (A) Yeast strains CTY182 (wi/d- 
type), CTY417 (ino1-13), and CTYIO0  (sacl-26)  were grown in 
inositol supplemented minimal defined medium and subsequently 
shifted to inositol-free medium. Samples were harvested immedi- 
ately after shift (0 rain) and at 180 rain postshift, and the inositol 
pools of the cells collected at each time point were determined for 
each strain as indicated (see Materials and Methods). Values  for the 
0 rain sample are represented by the solid black bars whereas the 
180-rain samples are represented by the stippled bars.  (B) Bulk 
membrane  glycerophospholipid  composition  of  wild-type  and 
~sac/strains at steady state. Yeast strains CTY182 (wild-type) and 
CTY244 (Asacl-296::HIS3) were cultured in YPD. Total glyeero- 
phospholipid was subsequently extracted, resolved into individual 
species by two-dimensional chromatography, and the phosphate 
content of each species quantitated by chemical assay. The data for 
each individual phospholipid species are presented as mole % of 
the indicated species measured relative to total glycerophospho- 
lipid plus phosphate remaining at the origin. Values for the wild- 
type strain are represented by the  solid black bars whereas the 
~sac/ values are represented by the stippled bars.  Phospholipid 
species are indicated as phosphatidylinositol (PI), phosphatidyl- 
serine (PS), phosphatidylcholine (PC), and phosphatidylethanol- 
amine (PE). 
Bulk Membranes Prepared From sacl Mutants Exhibit 
a Normal Phosphatidylinositol Content 
To determine whether sac1 mutants are somehow defective 
in the incorporation of inositol into PI, we compared the 
glycerophospholipid composition of bulk membranes pre- 
pared from wild-type and Asac/yeast. In these experiments, 
cells were cultured in YPD, an inositol-containing medium, 
total glycerophospholipids were extracted from the cells, 
displayed by two-dimensional paper chromatography, and 
individual glycerophospholipid species recovered and quan- 
titated  by  inorganic  phosphate  assay  (see  Materials  and 
Methods).  As demonstrated by the data in Fig.  10 B, the 
steady-state bulk membrane glycerophospholipid composi- 
tions of the wild-type and ~sacl  mutant strains were very 
similar. Indeed, both strains exhibited essentially the same 
PI content as a function of total glycerophospholipid (ca. 22 
mole%).  Similar results  were obtained when these  same 
strains  were  radiolabeled to  steady-state with  p2p]ortho- 
phosphate in phosphate-depleted YPD.  Additional [32p]or- 
thophosphate pulse-radiolabeling experiments (30-min pulse) 
in phosphate-depleted YPD medium also failed to reveal ob- 
vious  differences in  bulk  membrane  PI  content between 
wild-type and ~sac/strains (not shown). These data suggest 
that sac1 mutants were not grossly impaired in their ability 
to incorporate inositol into PI, and that sac1 mutants did not 
experience wholesale defects in PL metabolism. 
Discussion 
Our data indicate a physical association of SAClp with com- 
partments of the secretory pathway. First, immunoprecipita- 
tion experiments identified SAClp as an inabundant and un- 
glycosylated protein with an apparent molecular mass of 65 
kD (Fig.  1). Second, subeellular fractionation experiments 
demonstrated  that  SAClp  quantitatively  sedimented  with 
membranes (Fig. 2 A). Moreover, we found that SAClp was 
not extracted from membranes by alkaline  Na:CO3  treat- 
ment (Fig. 2 B) and, in other solubilization experiments, we 
observed that  SAClp  efficiently partitioned  into  a  Triton 
X-114 detergent phase. These data indicate that SAClp is an 
integral membrane protein. Third, immunofluoreseenee an- 
alyzes revealed a predominantly punctate pattern for SAClp 
staining in wild-type cells (Fig. 3 A, lane 2). Double-label 
fluorescence experiments indicated a substantial colocaliza- 
tion of the punctate SAClp staining with structures stained 
with probes specific for KEX2p, a resident polypeptide of 
yeast Golgi membranes (Fig. 5), and biochemical fraction- 
ation  data  confirmed a  significant presence of SAClp  in 
highly enriched Golgi fractions (Fig. 6; see above). Since it 
is the Golgi complex that is dysfunctional in sec14 strains, 
and sad mutations effect a bypass of the normally essential 
SEC14p  requirement  for yeast  Golgi  secretory function, 
these data  suggest that SAClp exerts a  local effect on the 
secretory competence of yeast Golgi membranes. We note, 
however, that SAClp-specific staining of what appears to be 
the yeast ER was also observed and that the prominence of 
this staining increased in direct proportion to the intraeellu- 
lar levels of SAClp (Fig. 3 A). Subeellular fractionation ex- 
periments further confirmed the presence of SAClp in a sub- 
fraction of ER membranes prepared from wild-type cells 
(Fig. 7). Thus, SAClp exhibits a steady-state residence in the 
yeast Golgi complex and in the yeast ER. The latter compo- 
nent of SAClp localization may provide some physical basis 
for the negative genetic interactions that have been observed 
between sad  c" alleles and several sec mutations that block 
protein transport through early stages of the secretory path- 
way (Cleves et ai., 1989). With regard to whether SACIp as- 
sociates with actin, we found that SAClp staining was not ob- 
The Journal of Cell Biology,  Volume 122, 1993  92 viously coincident with that of cortical actin patches or actin 
cables (Fig. 4). Thus, the present data do not support models 
invoking some global association of SAClp with the F-actin 
cytoskeleton. However,  our ability to coprecipitate SAClp 
and actin in native immunoprecipitation experiments still 
leaves open the possibility that SAClp  may associate with 
G-actin or actin oligomers in vivo (see above). 
How can the various data be incorporated into a model for 
SAClp function in vivo? Clearly, it is the loss of SAClp func- 
tion  that results  in  the bypass  of the  normally essential 
SEC14p requirement and in the suppression of act1-1  ~ (Fig. 
8). These data indicate that SAClp function is, in principle, 
antagonistic to both Golgi secretory function and some as- 
pect of actin function (perhaps actin assembly) in yeast. Fi- 
nally, the ability of sad alleles to cosuppress both actin and 
sec14 defects is a feature that is unique to sad as this charac- 
ter was not exhibited by the several other suppressor of actin 
sac alleles we have tested. For this reason, we believe that 
the mechanism of suppression, by SAClp dysfunction, of ac- 
tin and SEC14p defects includes features that are unique to 
the sad mechanism, and are not shared by the suppression 
mechanisms operating in the other  sac mutants we have 
tested. We assign considerable relevance to the specific ino- 
sitol auxotrophy exhibited by sad yeast strains not only be- 
cause this phenotype correlated with suppression of sec14 
defects in the survey of sac mutants (Fig. 9), but also because 
a similar inositol auxotrophy is associated with another sup- 
pressor of sec14 defects. The bsd2-1  mutation represents a 
dominant bypass suppressor of sec14 defects (Cleves et al., 
1991b). This allele also phenotypically manifests itself in an 
inositol  auxotrophy that  is  itself a  dominant trait  (T. P. 
McGee, and V. A. Bankaitis, unpublished data). The finding 
that inositol auxotrophy is a phenotype shared by two distinct 
classes of mutations that suppress sec14 defects suggests that 
this inositol auxotrophy is somehow reflective of the mecha- 
nism by which sec14 and actin defects are suppressed in sad 
strains. 
What possible  clues  might the  sad-associated  inositol 
auxotrophy provide with respect to SAClp function in cells 
and how SAClp dysfunction may influence the organization 
of the actin cytoskeleton and the cellular requirement for 
SEC14p?  As inositol is a direct precursor of the essential 
glycerophospholipid PI,  which itself provides the inositol 
moiety in the biosynthesis of inositol sphingolipids (Becker 
and Lester,  1980),  the inositol auxotrophy suggests some 
relationship between SAClp function and inositol glycero- 
phospholipid metabolism. It may be relevant that the mam- 
malian actin binding proteins profilin, gelsolin and cofilin 
exhibit a high affinity binding of phosphoinositides in vitro 
(Goldschmidt-Clermont et al., 1990; Lassing and Lindberg, 
1985; Yin et al., 1988; Yonezawa et al., 1991). Pollard and 
co-workers  have obtained  some biochemical evidence to 
support  the  notion that the cytosolic protein profilin se- 
questers phosphatidylinositol 4,5-bisphosphate (PIP2), thus 
rendering the bound PIP2 inaccessible to  degradation by 
unstimulated phospholipase  C  (Goldschmidt-Clermont et 
al.,  1991). These findings suggest a  biochemical link be- 
tween polyphosphoinositides, direct derivatives of the pre- 
ferred in vitro ligand of the SEC14p (i.e., PI; Daum and Pal- 
tauf, 1984),  and the regulation of actin assembly. 
The notion that SAClp function somehow interfaces with 
inositol glycerophospholipids is an attractive one as it sug- 
gests a general explanation, within an already familiar con- 
ceptual framework, for several of the outstanding pheno- 
types  associated  with  the  loss  of  SAClp  function  (i.e., 
suppression of act1-1  ~ and sec14 mutations, a novel inositol 
auxotrophy,  and  a  dramatic  disorganization of the  actin 
cytoskeleton in  sad  cells  challenged with low tempera- 
tures). The demonstration that sac1-26 mutants maintained 
substantially normal intracellular inositol pools in the face 
of challenge with inositol-free medium suggests that sad 
mutants retain wild-type de novo inositol biosynthetic capa- 
bility (Fig.  10 A).  Thus,  it seems unlikely that the sacl- 
associated inositol auxotrophy is the result of an inositol bio- 
synthetic defect. As the data also failed to indicate an obvious 
inositol utilization defect in Asad mutants (Fig.  10 B), it 
seems most likely that sac1 mutants require elevated levels 
of inositol for cell growth. An elevated inositol requirement 
might reflect some unusual turnover of inositol phospholip- 
ids in sad mutants, perhaps due to the loss of some SAClp- 
dependent inositol phospholipid sequestration function. The 
finding that bulk membrane PI levels of Asad mutants were 
indistinguishable from those of wild-type strains, however, 
does not reveal a wholesale defect in PI metabolism in sad 
mutants (Fig.  10  B).  It will be of interest to  determine 
whether sad mutations affect the PI content of yeast Golgi 
membranes. 
The idea that SAClp functions in inositol phospholipid se- 
questration has some important ramifications for the genetic 
(i.e., allele specificity) argument that SAClp is a candidate 
actin binding protein. If SAClp is involved in regulating (i.e., 
antagonizing) inositol PL turnover in cells, it need not ex- 
hibit a physical association with actin in order for loss of 
SAClp function to phenotypically  manifest itself  either in the 
observed disorganization of the actin cytoskeleton in vivo or 
in the observed allele-specific genetic interactions with act1 
mutations. For example, loss of SAClp function might upset 
the normal function of  other actin binding proteins that inter- 
act with actin in an inositol phospholipid-sensitive manner; 
thereby eliciting the observed allele-specific effects on actin 
cytoskeleton function and organization in cells via an in- 
direct lipid-mediated effect.  In this  scenario,  deregulated 
inositol PL turnover in sad mutants could suppress actin 
defects associated with inefficient polymerization of mutant 
G-actin  monomers,  yet  further  exacerbate  actin  defects 
associated with inefficient disassembly of mutant F-actin 
structures. It is interesting to note that actl-l,,  a mutation 
suppressed by sad, has been suggested to encode polymer- 
ization-defective actin whereas act1-2  ~, a mutation that ex- 
hibits synthetic lethality with sad, has been proposed to re- 
sult  in  the  formation  of  disassembly-defective  F-actin 
structures (Novick et al.,  1989).  Such a model describes a 
situation where  a  remarkable  allele  specificity might be 
generated not as a result of altered protein-protein interac- 
tions between two mutant polypeptides but, rather, from a 
more indirect alteration in the regulation of the assembly of 
one of  the mutant polypeptides. Alternatively, if SAClp itself 
binds G-actin in an inositol PL-sensitive manner, the various 
sac1 effects on the organization of the actin cytoskeleton and 
the accompanying sad-act1 genetic interactions can be ac- 
commodated into a model directly analagous to the profilin 
paradigm  as  proposed  by  Goldschmidt-Clermont  et  al. 
(1991). 
The data presented in this report also offer interesting pos- 
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cal functions might determine  the secretory  competence of 
yeast Golgi membranes.  Our previous results have suggested 
that PC synthesis via the CDP-choline pathway is not com- 
patible with Golgi secretory function in vivo, and that the es- 
sential  role of SEC14p is to moderate  the antagonism be- 
tween  these  two  cellular  functions  by  maintaining  an 
appropriate phospholipid composition in yeast Golgi mem- 
branes (Cleves et al, 1991a, b). One implication of those data 
is that excess PC is detrimental to Golgi secretory function. 
The  general  models  for SAClp  function entertained  here 
raise the alternative, but not mutually exclusive, possibility 
of a SEC14p-dependent  involvement of inositol phospholip- 
ids, or perhaps the local turnover of such phospholipids, in 
yeast Golgi secretory function. 
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